Medline
MDLN
35.45
-0.10
-0.28%
Medline
US · MDLN
#667 by market cap
Listed 2025
35.45
-0.10
-0.28%
Live - 5344 symbols - heartbeat 20s ago
· 2026-10-08 05:19
Pre-market
35.40
-0.14%
After-hours
35.26
-0.54%
Overnight
35.30
-0.42%
- Market cap
- 31.10B
- P/E (TTM)i
- 67.27
- P/Bi
- 2.69
- EPSi
- 1.43
- Div yieldi
- 0.00%
- 52W posi
- 20%
Reader sentiment
Are you bullish or bearish on MDLN?
Anonymous reader poll. Unscientific, not investment advice.
Analyst consensus 20 analysts
Buy
Avg price target
44.88 +26.6%
Price target rangecurrent 35.45
Low34.00
Avg44.88
High55.00
Buy 90%
Hold 10%
Sell 0%
Recent ratings (25)
| Date | Firm | Analyst | Rating | Target |
|---|---|---|---|---|
| 2026-09-25 | UBS | -- | BUY | 43.00 |
| 2026-09-23 | William Blair | -- | BUY | -- |
| 2026-09-22 | Truist Financial | -- | BUY | -- |
| 2026-09-16 | Leerink Partners | -- | BUY | 43.00 |
| 2026-09-10 | Leerink Partners | -- | BUY | 34.05 |
| 2026-08-27 | BTIG | -- | BUY | 55.00 |
| 2026-08-26 | Truist Financial | -- | BUY | -- |
| 2026-08-17 | Barclays | -- | BUY | 45.00 |
| 2026-08-14 | Tigress Financial | -- | BUY | 55.00 |
| 2026-08-12 | J.P. Morgan | -- | BUY | 46.00 |
| 2026-08-11 | Wells Fargo | -- | HOLD | 34.00 |
| 2026-08-11 | Tigress Financial | -- | BUY | 55.00 |
| 2026-08-10 | TD Cowen | -- | BUY | 45.00 |
| 2026-08-09 | TD Cowen | -- | BUY | 45.00 |
| 2026-08-06 | Mizuho Securities | -- | BUY | 48.00 |
| 2026-08-06 | BofA Securities | -- | BUY | -- |
| 2026-08-06 | Truist Financial | -- | BUY | 47.00 |
| 2026-08-06 | Baird | -- | BUY | 42.00 |
| 2026-08-06 | Morgan Stanley | -- | BUY | 48.00 |
| 2026-08-06 | Evercore | -- | BUY | 39.00 |
| 2026-08-06 | Deutsche Bank | -- | HOLD | 37.00 |
| 2026-08-06 | Stifel | -- | BUY | 45.00 |
| 2026-08-05 | William Blair | -- | BUY | -- |
| 2026-08-05 | BTIG | -- | BUY | 55.00 |
| 2026-08-05 | BMO Capital | -- | BUY | 47.00 |
Quant vs Street three independent views, side by side
StockVane factor grade
D+
Momentum strategy signal
Sell
Analyst consensus
Buy
Mostly aligned, one view stands apart.
Not investment advice. The factor grade ranks this stock on fundamentals against StockVane's covered universe; the momentum strategy signal is a rules-based backtest, not a recommendation; analyst consensus reflects sell-side coverage. The three use different methods and can reasonably disagree.
Price target trend monthly average, last 3 years
Earnings history price reaction on the day
| Period | Report date | Session | Options expected | Actual move |
|---|---|---|---|---|
| 2026/Q2 | 2026-08-05 | -- | ±11.24% | -12.79% (beat) |
| 2026/Q1 | 2026-05-06 | -- | ±8.24% | -7.30% (in line) |
| 2025/Q4 | 2026-02-25 | -- | -- | -3.62% |
"Options expected" is the pre-earnings options market's implied move (a straddle-style estimate), shown next to what actually happened.
Quote time 2026-10-08 05:19:38 · For reference only, not investment advice and not tailored to your situation.